表紙：アセタゾラミド市場：規模、シェア、見通し、機会分析（2022年～2028年）

市場調査レポート

商品コード

1084579

アセタゾラミド市場：規模、シェア、見通し、機会分析（2022年～2028年）

Acetazolamide Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月24日 | 発行: Coherent Market Insights

| ページ情報: 英文 152 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 705,420円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,097,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,567,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の緑内障の有病率およびその危険因子の増加が、予測期間中のアセタゾラミドに対する需要を促進しています。さらに、アセタゾラミドは高山病の予防によく使用されており、このことが薬剤の有用性を高めています。

当レポートでは、世界のアセタゾラミド市場について調査し、市場の概要とともに、製剤別、用途別、流通チャネル別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

ヒートマップ分析
企業プロファイル
- Teva Pharmaceutical Industries Ltd.
- Accord Healthcare Ltd.(Intas Pharmaceuticals Limited)
- Heritage Pharmaceuticals Inc.
- Nostrum Laboratories Inc.
- Novast Laboratories Ltd.
- Cadila Healthcare(Zydus Pharmaceuticals(USA)Inc.)
- Lannett Company, Inc.
- Strides Shasun Limited
- X-GEN Pharmaceuticals, Inc.

第9章セクション

Product Code: CMI2396

Acetazolamide is an enzyme inhibitor, which acts specifically on carbonic anhydrase. Acetazolamide, sold under the trade name Diamox, is used to treat glaucoma, altitude sickness, epilepsy, fluid retention, heart failure, and seizures.

In addition to this, acetazolamide (carbonic anhydrase inhibitor) is effective in controlling fluid secretions, to treat certain convulsive disorders, and promotes diuresis in instances of abnormal fluid retention such as cardiac edema.

Increasing effectiveness of acetazolamide in treating other indication such as drug induced edema and brain tumor glioblastoma is offering growth prospective for key drug manufacturers in this market. For instance, according to a new study published in Science Translational Medicine Journal in July 2018, acetazolamide may also be effective in treating glioblastoma, fast-growing brain tumor. As per the study findings, acetazolamide can restore temozolomide's (TMZ) ability to kill tumor cells. Furthermore, the study suggested that the combination of acetazolamide with TMZ may be an effective subgroup to consider for trial for patients with high BCL-3 expression.

Market Dynamics

Increasing prevalence of glaucoma and its risk factors among global population is propelling demand for acetazolamide during the forecast period. Moreover, acetazolamide is commonly used for preventing high altitude illness, this increases the utility of the drug.

For instance, according to the International Journal of Advanced Medical and Health Research, 2015, glaucoma is seen to be the second major reason causing blindness among people across the world, followed by cataract.

Furthermore, according to the BrightFocus Foundation, June 2021 data findings, over 3 million Americans suffer from glaucoma, out of which 2.7 million (aged 40 and older) are affected by its most common form, open-angle glaucoma. Also, high prevalence of eye disorder in the geriatric population and nutritional deficiency in the younger population due to changing food habits are other factors affecting the health of the people globally, which might lead to boost growth of acetazolamide market. Acetazolamide capsule taken once a day by patients with chronic glaucoma offers a substantial pressure-lowering effect, which lasts at least 23 hours.

Acetazolamide helps in preventing acute mountain sickness and has fewer side effects than alternative drugs such as dexamethasone, which can mask symptoms and therefore carries greater risk.

Key features of the study:

This report provides in-depth analysis of acetazolamide market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, drug approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global acetazolamide market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as part of this study include Teva Pharmaceutical Industries Ltd., Accord Healthcare Ltd. (Intas Pharmaceuticals Limited), Heritage Pharmaceuticals Inc., Nostrum Laboratories Inc., Novast Laboratories Ltd., Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.), Lannett Company, Inc., Strides Shasun Limited, and X-GEN Pharmaceuticals, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future drug launch, manufacturing up-gradation, market expansion, and marketing tactics
The global acetazolamide market report caters to various stakeholders in this industry including investors, suppliers, acetazolamide based product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the acetazolamide market.

Detailed Segmentation:

Global Acetazolamide Market, By Formulation:
Tablets
Capsules
Injection
Global Acetazolamide Market, By Application:
Glaucoma
Epilepsy
Drug-induced Edema
Altitude Sickness
Fluid Retention
Heart Failure
Seizures
Global Acetazolamide Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Acetazolamide Market, By Geography:
North America
- By Country:
U.S.
Canada
- By Formulation:
Tablets
Capsules
Injection
- By Application
Glaucoma
Epilepsy
Drug-induced Edema
Altitude Sickness
Fluid Retention
Heart Failure
Seizures
- By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Europe
- By Country:
Germany
France
Italy
UK
Spain
Russia
Rest of Europe
- By Formulation:
Tablets
Capsules
Injection
- By Application
Glaucoma
Epilepsy
Drug-induced Edema
Altitude Sickness
Fluid Retention
Heart Failure
Seizures
- By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Asia Pacific
- By Country:
China
India
Japan
South Korea
Australia
Rest of Asia Pacific
- By Formulation:
Tablets
Capsules
Injection
- By Application
Glaucoma
Epilepsy
Drug-induced Edema
Altitude Sickness
Fluid Retention
Heart Failure
Seizures
- By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Middle East
- By Country:
GCC
Israel
Rest of Middle East
- By Formulation:
Tablets
Capsules
Injection
- By Application
Glaucoma
Epilepsy
Drug-induced Edema
Altitude Sickness
Fluid Retention
Heart Failure
Seizures
- By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Latin America
- By Country:
Brazil
Argentina
Mexico
Rest of Latin America
- By Formulation:
Tablets
Capsules
Injection
- By Application
Glaucoma
Epilepsy
Drug-induced Edema
Altitude Sickness
Fluid Retention
Heart Failure
Seizures
- By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Africa
- By Country:
South Africa
Central Africa
North Africa
- By Formulation:
Tablets
Capsules
Injection
- By Application
Glaucoma
Epilepsy
Drug-induced Edema
Altitude Sickness
Fluid Retention
Heart Failure
Seizures
- By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Company Profiles
Teva Pharmaceutical Industries Ltd.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments
- Strategies
Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
Heritage Pharmaceuticals Inc.
Nostrum Laboratories Inc.
Novast Laboratories Ltd.
Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.)
Lannett Company, Inc.
Strides Shasun Limited
X-GEN Pharmaceuticals, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Formulation
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Epidemiology
Key Developments
Drug Approvals and Launches
Strategic Collaborations & Acquisitions
Regulatory Scenario
Pipeline Analysis

4. Global Acetazolamide Market, By Formulation, 2022 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)

5. Global Acetazolamide Market, By Application, 2022 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Drug indicted Edema
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Altitude Sickness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Fluid Retention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Seizures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)

6. Global Acetazolamide Market, By Distribution Channel, 2022 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2028, (US$ Million)

7. Global Acetazolamide Market, By Region, 2022 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
North America
- Market Size and Forecast, By Formulation, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2022 - 2028, (US$ Million)
U.S.
Canada
Europe
- Market Size and Forecast, By Formulation, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2022 - 2028, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Formulation, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2022 - 2028, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Formulation, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2022 - 2028, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
- Market Size and Forecast, By Formulation, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2022 - 2028, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
- Market Size and Forecast, By Formulation, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2022 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2022 - 2028, (US$ Million)
GCC Countries
Israel
Rest of Middle East

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- Teva Pharmaceutical Industries Ltd.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- Heritage Pharmaceuticals Inc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- Nostrum Laboratories Inc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- Novast Laboratories Ltd.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.)
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- Lannett Company, Inc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- Strides Shasun Limited
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies
- X-GEN Pharmaceuticals, Inc.
Company Overview
Drug Portfolio
Financial Performance
Recent Developments/Updates
Key Strategies

9. Section

References
Research Methodology
About Us and Sales Contact

アセタゾラミド市場：規模、シェア、見通し、機会分析（2022年～2028年）

Acetazolamide Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場概要

第3章市場力学、規制、および動向分析

第4章世界のアセタゾラミド市場：製剤別、2022年～2028年、（100万米ドル）

第5章世界のアセタゾラミド市場：用途別、2022年～2028年、（100万米ドル）

第6章世界のアセタゾラミド市場：流通チャネル別、2022年～2028年、（100万米ドル）

第7章世界のアセタゾラミド市場：地域別、2022年～2028年、（100万米ドル）

第8章競合情勢

第9章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Acetazolamide Market, By Formulation, 2022 - 2028, (US$ Million)

5. Global Acetazolamide Market, By Application, 2022 - 2028, (US$ Million)

6. Global Acetazolamide Market, By Distribution Channel, 2022 - 2028, (US$ Million)

7. Global Acetazolamide Market, By Region, 2022 - 2028, (US$ Million)

8. Competitive Landscape

9. Section

アセタゾラミド市場：規模、シェア、見通し、機会分析（2022年～2028年）

Acetazolamide Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場概要

第3章 市場力学、規制、および動向分析

第4章 世界のアセタゾラミド市場：製剤別、2022年～2028年、（100万米ドル）

第5章 世界のアセタゾラミド市場：用途別、2022年～2028年、（100万米ドル）

第6章 世界のアセタゾラミド市場：流通チャネル別、2022年～2028年、（100万米ドル）

第7章 世界のアセタゾラミド市場：地域別、2022年～2028年、（100万米ドル）

第8章 競合情勢

第9章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objective and Assumption

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Acetazolamide Market, By Formulation, 2022 - 2028, (US$ Million)

5. Global Acetazolamide Market, By Application, 2022 - 2028, (US$ Million)

6. Global Acetazolamide Market, By Distribution Channel, 2022 - 2028, (US$ Million)

7. Global Acetazolamide Market, By Region, 2022 - 2028, (US$ Million)

8. Competitive Landscape

9. Section

第1章調査目的・前提条件

第2章市場概要

第3章市場力学、規制、および動向分析

第4章世界のアセタゾラミド市場：製剤別、2022年～2028年、（100万米ドル）

第5章世界のアセタゾラミド市場：用途別、2022年～2028年、（100万米ドル）

第6章世界のアセタゾラミド市場：流通チャネル別、2022年～2028年、（100万米ドル）

第7章世界のアセタゾラミド市場：地域別、2022年～2028年、（100万米ドル）

第8章競合情勢

第9章セクション